Safety, Immunogenicity, Lot-to-lot Consistency Study of the HBV Vaccine, HEPLISAV Compared to Engerix-B Vaccine
This study has been completed.
Sponsor:
Dynavax Technologies Corporation
Information provided by (Responsible Party):
Dynavax Technologies Corporation
ClinicalTrials.gov Identifier:
NCT01005407
First received: October 29, 2009
Last updated: January 11, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |